The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 19, 2019
Filed:
Jun. 02, 2015
Applicant:
Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;
Inventors:
Philippe Le Bouteiller, Toulouse, FR;
Armand Bensussan, Paris, FR;
Assignees:
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Paris, FR;
MABLIFE, Evry, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/22 (2006.01); A61K 39/395 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 39/3955 (2013.01); C07K 16/22 (2013.01); C07K 16/2803 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01);
Abstract
The present invention relates to the use of at least one anti-CD 160 antibody, preferably a compound selected from CL1-R2 monoclonal antibody (which may be obtained by the hybridoma CNCM 1-3204), its conservative fragments and its conservative derivatives, for preparing a drug designed to treat neovascular eye diseases.